Dr Alexander Veith


Alexander is Germany Life Sciences Sector Lead. He specializes in national and cross-border M&A transactions with a particular focus on the Life Sciences and the Technology sectors.
Alexander also advises clients on a wide variety of matter, including venture capital investments, joint ventures and complex corporate reorganisations. Alexander regularly advises clients on M&A auction processes, executing successful transactions both for sellers and for buyers.

Alexander’s clients comprise national and international corporates, PE clients as well as VC investors. He has more than 20 years experience with M&A transactions. Alexander´s clients appreciate his efficient and pragmatic way of working.


Representative matters

A healthcare information, services and technology company in relation to the acquisition of DAVASO, a leading service provider for statutory health insurers in Germany with a focus on claims processing, auditing and billing services.

Enovis Corporation on the acquisition of a stake in German start-up Orthopy Health GmbH.

Vision Healthcare, a fast-growing European online platform for food supplements, cosmetics and health products, on the share purchase agreement with the shareholder of Vitamaze GmbH for the acquisition of 100% of shares in Vitamaze GmbH.

Vision Healthcare on the acquisition of 100% of the shares in AixSwiss BV.

Published Work

  • Veith A. (2012) "Verschaerfung von Ad-hoc-Meldepflichten bei gestreckten Entscheidungsprozessen", Der Betrieb, 16/2012
  • Veith A., Schmid S. (2012) "Abschluss und Beendigung von Beherrschungs- und Gewinnabfuehrungsvertraegen im GmbH-Konzern", Der Betrieb 13/2012, page 728 ff.
  • Veith A. (2009) "Haftung der Mitglieder eines fakultativen GmbH-Aufsichtsrates", Status Recht, 6/2009, page 149
  • Veith A. (2007) "Qual der Wahl bei der richtigen Unternehmensform – Ist die Limited eine ernsthafte Alternative zur GmbH?", Sonderausgabe azur

Speaking Engagements

  • Speaker, Corporate law topics, client events.


  • Ranked in “Best Lawyers”, Handelsblatt, 2023
  • European M&A Lawyer of the Year, Life Science Awards Europe, 2021
  • “Frequently recommended lawyer”, JUVE Handbuch, 2011-2023
  • “He is extremely impressive and a very good negotiator - he is exactly as you would wish a lawyer to be.”, Chambers Germany 2019
  • “Excellent legal skills, target-oriented and very constructive” (competitor), JUVE Handbuch, 2022/2023



Admitted as German Rechtsanwalt, 2002


Dr iur, Johannes Gutenberg Universität Mainz, Germany, 2002

Second German Law Degree, 2001

First German Law Degree, 1999


English, German
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.